Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimen.
Hee-Jeong ChoSang-Kyung SeoDong Won BaekSung-Woo ParkYoo-Jin LeeSang-Kyun SohnHo-Sup LeeWon Sik LeeJi Hyun LeeSung Hyun KimJoon-Ho MoonPublished in: Yeungnam University journal of medicine (2018)
A good adherence to a frontline VMP regimen resulted in favorable long-term survival. Adequate management of AEs will be needed to achieve favorable outcomes in elderly patients with MM.